NeuroRPM
PrivateLast Round
Accelerator
Sep 19, 2024
Total Funding Raised
$2,500
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuroRPM operates in Healthcare & Life Sciences and is based in Washington D.C.. Its latest recorded funding round was an Accelerator round in September 2024.
NeuroRPM is a medtech company that has developed an FDA-cleared, AI-powered remote monitoring application for Parkinson's disease that works with the Apple Watch.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Clinical Trials, Health IoT, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroRPM Comparables
Compare NeuroRPM with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rune Labs | 93% | |
| BioSensics | 82% | |
| Modality.AI | 67% |
For institutional investors. Book with your work email.
NeuroRPM Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroRPM Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AgeTech Collaborative | Accelerator |
| DC Department of Small and Local Business Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 4759% MoM, from 37 to 1.8K.
- Jul 1, 2025
Monthly visitors grew 63% MoM, reaching 1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withOct 6, 2026
NeuroRPM Inc. joins Athenahealth, Inc.'s ecosystem of integrated solutions, enabling clinicians to incorporate passive Parkinson’s monitoring data into athenaOne workflows; the ecosystem is available to more than 170,000 clinicians on Oct 6th '26'.
For institutional investors. Book with your work email.
NeuroRPM Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroRPM's valuation, stock price, and market status.
Is NeuroRPM a public or private company?
NeuroRPM is a private company.
What is the current stock price of NeuroRPM?
NeuroRPM is a private company, so its shares have no public market price. Caplight tracks NeuroRPM's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroRPM worth (valuation)?
Valuation information for NeuroRPM is not publicly available.
Can I buy NeuroRPM stock?
NeuroRPM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroRPM's last funding round?
NeuroRPM's most recent funding round was Accelerator on September 19, 2024.
Who are the main investors in NeuroRPM?
Key investors in NeuroRPM include AgeTech Collaborative.
Will NeuroRPM IPO soon?
No public IPO plans have been announced for NeuroRPM.
How can I track NeuroRPM secondary market activity?
Caplight tracks bids, offers, and trades in NeuroRPM's shares on secondary markets.